| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $232.3M | +21.1% |
| Cost of Revenue | $65.1M | +23.7% |
| Gross Profit | $167.2M | +20.1% |
| R&D Expense | $30.5M | -3.9% |
| SG&A Expense | $64.9M | +9.5% |
| Operating Income | -$41.1M | +23.2% |
| Pre-tax Income | -$33.6M | -2.6% |
| Income Tax | $5.0M | +1002.4% |
| Net Income | -$41.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $227.2M | -15.3% |
| Short-term Investments | $2.6M | +8.7% |
| Accounts Receivable | $66.5M | +20.7% |
| Current Assets | $306.3M | -8.3% |
| Total Assets | $415.5M | +6.9% |
| Current Liabilities | $142.7M | +28.4% |
| Total Liabilities | $172.4M | +29.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$774K | -115.4% |
| Capital Expenditures | $3.9M | +56.6% |
| Investing Cash Flow | -$21.5M | -535.2% |
| Financing Cash Flow | -$17.1M | -108.6% |
| Free Cash Flow | -$4.6M | -280.1% |
| -18.2% |
| EPS (Basic) | -$0.23 | +52.1% |
| Stockholders' Equity |
| $229.1M |
| -8.5% |